This bill proposes to update current statutes by appropriating $10,000,000 from the state general fund for the fiscal year 2025-2026 to the Department of Health Services. The funds are designated for awarding grants for clinical trials or research on midomafetamine as a treatment for post-traumatic stress disorder, specifically targeting entities that have completed late-stage clinical trials and are involved in the FDA drug review process for this treatment.

Additionally, the bill includes a provision that exempts this appropriation from the lapsing of appropriations as outlined in section 35-190 of the Arizona Revised Statutes. This change aims to ensure that the allocated funds remain available for their intended purpose without the risk of being reabsorbed into the general fund at the end of the fiscal year.